Vestal Point Capital’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.82M | Sell |
2,515,000
-850
| -0% | -$952 | 0.15% | 60 |
|
|
2025
Q1 | $1.99M | Buy |
2,515,850
+50,850
| +2% | +$40.2K | 0.14% | 54 |
|
|
2024
Q4 | $4.07M | Buy |
2,465,000
+780,000
| +46% | +$1.29M | 0.24% | 57 |
|
|
2024
Q3 | $5.9M | Sell |
1,685,000
-315,000
| -16% | -$1.1M | 0.45% | 44 |
|
|
2024
Q2 | $6.56M | Buy |
2,000,000
+1,200,000
| +150% | +$3.94M | 0.49% | 42 |
|
|
2024
Q1 | $5.87M | Sell |
800,000
-490,000
| -38% | -$3.6M | 0.49% | 41 |
|
|
2023
Q4 | $4.82M | Buy |
+1,290,000
| New | +$4.82M | 0.51% | 33 |
|